Direct antiglobulin test positive blood donors and blood transfusion safety
Journal Title: Chinese Journal of Blood Transfusion - Year 2025, Vol 38, Issue 4
Abstract
Direct antiglobulin test (DAT), also known as Coomb's test, is a method used in blood immunology to detect whether the surface of red blood cells is sensitized by immunoglobulin or complement. It is mainly used in the diagnosis of autoimmune hemolytic anemia (AIHA), neonatal hemolytic anemia, hemolytic transfusion reaction and blood matching during blood transfusion. DAT positive has always been the focus of researchers, because it has an important impact on the efficacy of blood transfusion. In recent years, there has been extensive research on the identification of DAT positivity types and the distribution characteristics of diseases in clinical patients, and the study on hemolytic disease of the newborn has also been popular. However, the transfusion safety of DAT-positive blood donors has been a hot topic in the field of blood transfusion for many years. Moreover, there is no clear requirement from the state on the handling of DAT-positive blood and whether DAT-positive blood donors should be deferred from donation. Therefore, this article reviews the serological studies on DAT immunotyping and IgG subtype typing of voluntary blood donors, as well as the impact of DAT-positive blood on blood transfusion safety, in order to provide references for the blood issuance strategy of DAT-positive blood and whether DAT-positive blood donors should be deferred.
Authors and Affiliations
Xiaomei JIE, Ziyi HE, Yingming HU, Menghui BEI
Keywords
Related Articles
- EP ID EP766606
- DOI 10.13303/j.cjbt.issn.1004-549x.2025.04.018
- Views 14
- Downloads 0
Hemophilia A with reduced coagulation factor Ⅺ: a case report and literature review
Objective To investigate the possible molecular pathogenesis of a child with hemophilia A accompanied by coagulation factor Ⅺ reduction by testing coagulation-related indicators and genotyping in the child and his family...
Research progress in clinical application of lymphoplasmapheresis in immune-related diseases
Lymphoplasmapheresis(LPE) is a combination of plasma exchange and lymphocyte separation technology. It can not only remove autoimmune antibodies, but also remove the immune active cells producing these antibodies. At the...
Factors influencing hemolysis rate of leukocyte-reduced red blood cells at the end of preservation period in blood donors
Objective To compare the current standards and explore the influencing factors for hemolysis rate of leukocyte-reduced red blood cells at the end of the preservation period, in order to formulate reasonable internal cont...
Clinical application progress of granulocyte transfusion
Granulocyte is granular leukocytes in blood, which play an important role in anti-infection treatment and cancer-killing activity. In clinical, allogeneic granulocyte transfusion can be applied for anti-infection treatme...
Intraoperative cell salvage in cesarean delivery of women with placenta previa:a meta-analysis
Objective To systematically evaluate the safety and efficacy of intraoperative cell salvage (IOCS) for placenta previa women undergoing cesarean section. Methods The PubMed, Web of Science, Embase, the Cochrane Library o...